1-2 punchToday is a combination of VRX getting a big downgrade, charges being laid reminding everyone about the cloud that hangs over these two stocks. IBB still in pullback mode doesn't help either.
Valeant Pharma (NYSE:VRX) Downgrade
Mizuho has cut Valeant Pharma (NYSE:VRX) stock to Underperform in an analyst note sent to investors and clients on Wednesday morning, and has set a 12 month PT at $11. VRX’s old rating was Neutral.
I just picked up some shares at $3.40 CAD > bargain!